Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT06128005 Recruiting - Pressure Ulcer Clinical Trials

Pressure Injury、Caregiver、Knowledge Translation

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Background and importance: In 2003, a pressure injury is listed as one of the indicators of care quality in clinical setting by Taiwan joint commission on hospital accreditation. That reflects that a pressure injury is a significant heath care issue. Nowadays, it still constantly happens at hospitals, home, and nursing homes: Pressure injuries cause pain, and increase length of hospital stay, rehospitalization rate, and death rate. In current clinical practice, standardized guidelines and basic principles are followed for pressure injury management, and it is found that most of the caregivers are unsure about what are the consequences of having pressure injuries and how to manage and prevent them. Therefore, the caregivers are more passive, and feel nervous and confused. In literature, there are guidelines for pressure injury prevention and management. However, they are primarily designed for heath professionals. As a result, to achieve evidence-based practice and knowledge translation, I hope to make individual management plans for each patient, provide caring support, and follow up with patients. And caregivers can benefit from knowledge, attitude, practice, and caring effect.

NCT ID: NCT06127056 Recruiting - Clinical trials for Non-suicidal Self-injury

Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI)

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

To investigate the intervention effect of high-definition transcranial alternating current stimulation (HD-tACS) on patients with Non-suicidal Self-injury (NSSI) and its underlying neural mechanism by magnetic resonance imaging (MRI).

NCT ID: NCT06124924 Recruiting - Acute Kidney Injury Clinical Trials

SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

Start date: April 1, 2024
Phase: Early Phase 1
Study type: Interventional

SGLT2i have been shown to reduce risk for mortality, progression of chronic kidney disease, and cardiovascular outcomes in these populations. Yet, because SGLT2i can have an acute hemodynamic effect on kidney function, in clinical practice providers are wary of providing these medications to patients who have established indications but recently had acute kidney injury (AKI). This is a pilot interventional study to collect process-data (measures of recruitment and measures of adherence) that can be used to establish feasibility for a larger pilot randomized trial in the future. The study aims to conduct a small randomized intervention trial with two arms, with approximately 10-12 patients in the intervention arm and 5-6 in the control arm. The intervention will be providing a prescription for a SGLT2i based on established criteria for this FDA-approved class of drugs, and the control will be usual care (through which, control arm participants will also have access to this FDA-approved class of drugs - expect receipt of a SGLT2i in the control arm to be rare, but a degree of crossover will be expected).

NCT ID: NCT06121661 Recruiting - Wounds and Injuries Clinical Trials

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Start date: February 21, 2023
Phase: Phase 1
Study type: Interventional

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows: 1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use); 2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits; 3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

NCT ID: NCT06109909 Recruiting - Clinical trials for Mild Traumatic Brain Injury

Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to complete a pilot study testing the feasibility and acceptability of low-intensity pulse-based transcranial stimulation (LIP-tES) neurofeedback intervention for reducing photosensitivity symptoms in Veterans with a history of mild traumatic brain injury (mTBI). The study will also complete resting-state MRI scans to assess neurophysiological markers of photosensitivity and changes associated with LIP-tES intervention.

NCT ID: NCT06108999 Recruiting - Wound Heal Clinical Trials

Management of Acute and Chronic Wounds With Hyaluronic Acid

Start date: July 29, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the performance and safety of Connettivina Bio, when used in the management of wounds. Moreover, the study will evaluate the correlation of the 'dressing system' (formed by the Connettivina Bio primary dressing plus a secondary one) used in different care settings. The study will include Italian healthcare facilities.

NCT ID: NCT06108362 Recruiting - Acute Kidney Injury Clinical Trials

Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients

Start date: August 18, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of intraoperative terlipressin on the incidence of early postoperative acute kidney injury in deceased doner liver transplantation. Patients were randomly divided into experimental group and control group by numerical randomization table. The experimental group was injected with terlipressin perioperative and the control group was injected with placebo

NCT ID: NCT06105229 Recruiting - Acute Kidney Injury Clinical Trials

Clinical Value of Plasma Humanin in Acute Kidney Injury

Start date: August 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to assess the clinical value of humanin in acute kidney injury. The main questions it aims to answer are:whether Humanin can be a novel marker for predicting AKI Researchers will compare humanin concentration in healthy people to see if humanin can be a novel marker for predicting AKI

NCT ID: NCT06104384 Recruiting - Chronic Pain Clinical Trials

Characteristics of Injury Claims by Chronic Pain Patients

Start date: January 2, 2018
Phase:
Study type: Observational

Chronic pain is associated with injuries and disabilities. This prospective observational study explores the injury or disability claims made by chronic pain patients. It evaluates the socio-demographics of the patient population. It explores the impact of pain clinic services on the patients' injury rehabilitation, insurance claim outcome, and socioeconomic situation.

NCT ID: NCT06103812 Recruiting - Wound Heal Clinical Trials

Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds

Start date: March 24, 2022
Phase:
Study type: Observational

Evaluate the performance and safety of the use of Hyalo4 Skin Gel in terms of wound management